查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2003130

5G赋能医疗设备市场：2026-2032年全球市场预测（依产品类型、连接方式、网路架构、组件、应用和最终用户划分）

5G-enabled Medical Devices Market by Product Type, Connectivity Type, Network Architecture, Component, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，5G医疗设备市场价值将达到 12.2 亿美元，到 2026 年将成长到 15.1 亿美元，到 2032 年将达到 53.8 亿美元，复合年增长率为 23.62%。

主要市场统计数据
基准年 2025 12.2亿美元
预计年份：2026年 15.1亿美元
预测年份 2032 53.8亿美元
复合年增长率 (%) 23.62%

这是一本权威的入门指南，概述了第五代通讯技术如何重新定义整个医疗保健生态系统中的临床设备和交付模式。

第五代无线通讯技术的引入正在改变医疗设备在临床和非临床环境中的设计、交付和管理方式。本报告探讨了确定性连接、超低延迟和高设备密度如何催生新型诊断、监测和治疗设备，同时也对网路安全、法规遵循和临床检验检验了新的要求。从医疗设备製造商到医疗系统营运商和网路供应商，相关人员面临着一个快速发展的技术和商业性环境，在这个环境中，互通性、资料完整性和病患安全是创新与监管的交汇点。

简要分析加速临床级连接技术普及和提高其标准的关键技术、监管和营运变革。

近年来，一系列变革加速了互联医疗设备的普及应用，并重塑了临床工作流程。首先，边缘运算和分散式分析技术的成熟降低了资料撷取与临床操作之间的门槛，从而在关键应用场景中实现了即时决策支援。同时，私有网路和混合网路的日益普及建构了可控的互联环境，能够有效管理延迟、吞吐量和安全参数，满足临床层级要求。

对 2025 年美国关税措施对供应链策略、采购趋势和医疗设备部署计画的影响进行现实评估。

美国2025年实施的关税政策对依赖全球零件采购的医疗设备製造商的供应链、筹资策略和产品成本结构产生了一系列累积影响。依赖海外製造的无线设备、半导体模组或专用感测器的製造商正面临不断上涨的到货成本和更长的前置作业时间，迫使他们重新评估采购管道和库存管理优先顺序。这些压力正推动供应商多元化、增加关键零件的国内采购以及建立策略伙伴关係关係，以减轻未来政策变化的影响。

全面而全面的細項分析，展示了产品类型、应用、最终用户、连接方式、架构和组件如何影响策略和设计。

細項分析揭示了不同设备类型、应用领域、最终用户、连接方式、网路架构和组件堆迭的部署模式和产品设计优先级差异。在产品类型细分中，诊断设备包括影像设备、临床实验室设备和照护现场诊断设备。影像设备进一步细分为CT扫描仪、MRI扫描仪和超音波诊断设备，而临床实验室设备则分为血液分析仪和尿液检查。这些高频宽、高精度设备优先考虑吞吐量、确定性连接和安全的资料管道。监测设备包括心电图（ECG）监测、血糖监测、呼吸监测和生命征象监测。心电图监测分为家庭使用和医院使用，血糖监测分为连续测量和间歇测量，呼吸监测涵盖睡眠呼吸中止症候群和肺功能测试，生命征象监测涵盖血压、心率和体温。低功耗、遥测连续性和强大的边缘分析能力是这些监测领域的优先考虑因素。治疗设备包括输液帮浦、胰岛素帮浦、神经刺激设备和呼吸治疗设备。输液帮浦分为胰岛素输注帮浦和镇痛输注帮浦；胰岛素帮浦分为贴片式和管式；神经刺激设备分为深部脑部刺激器和脊髓刺激设备；呼吸治疗设备分为持续性正压呼吸器（CPAP）机和人工呼吸器。治疗设备领域对连接可靠性、故障安全运作以及设备间的严格互通性提出了极高的要求。

战略区域概览，描述了美洲、欧洲、中东和非洲以及亚太地区等各个区域如何展现其独特的采用驱动因素和部署重点。

区域趋势对5G医疗设备的技术采纳曲线、监管重点和商业性伙伴关係产生了显着影响。在美洲，学术医疗中心私人网路的试点部署，以及对远端医疗和远端患者监护的强劲需求，正促使医疗系统和设备製造商优先考虑快速试点部署互联解决方案。北美买家高度关注网路安全和合规途径，而支付方也越来越重视能够大幅减少急诊治疗需求的医疗设备。该地区的采购流程往往倾向于能够展现明确临床和营运投资回报率的整合解决方案，医疗设备原始设备製造商 (OEM) 与主要网路供应商之间的伙伴关係也十分普遍，旨在降低部署风险。

对生态系统中供应商、整合商和软体合作伙伴的竞争关係、伙伴关係模式和策略挑战进行深入分析。

5G赋能的医疗设备领域的竞争动态由众多参与者共同塑造，包括医疗设备製造商 (OEM)、网路营运商、云端和分析供应商、系统整合商以及专业软体供应商。医疗设备OEM正在拓展产品系列，将嵌入式连接和边缘运算功能融入其中，并日益加强与通讯业者和整合商的合作，以在临床环境中检验端到端解决方案。网路营运商和专用网路专家则将託管连接和保障服务定位为其临床解决方案体系的重要组成部分，提供针对医疗应用场景量身定制的服务等级协定 (SLA) 和互通性保证。

为製造商、医疗保健系统和技术合作伙伴提供优先考虑的、可操作的建议，以加速安全且可扩展的部署。

计划使用5G医疗设备的领导者应优先考虑制定一套切实可行的策略，使技术能力与临床和商业性目标保持一致。首先，为了降低网路风险并满足监管要求，应从产品初始设计到上市后监测都遵循「安全设计」和零信任架构的原则。儘早投资于硬体模组化和软体定义无线电（SDR）技术，将使产品能够在非独立组网（NSA）、独立组网（SA）和专用网路配置下运行，从而降低重新设计成本并加快部署准备。

对结合一手访谈、技术检验、供应链映射和情境分析的多方面研究途径进行透明的解释。

本研究采用多方面方法，旨在从技术、临床和商业性观点交叉检验5G医疗设备。主要定性资料透过对临床负责人、设备工程师、网路专家和采购主管的结构化访谈获得，以直接了解部署经验和挑战。专家小组检验了有关无线电波传播、边缘运算部署和互通性限制的技术假设。次要研究涵盖标准文件、监管指南、技术白皮书和公开案例研究，并基于既定实践和近期部署情况进行分析。

简洁的结论强调了将 5G 技术能力转化为临床价值和永续商业性优势的关键优先事项。

将可靠的 5G 连线部署到医疗设备中，为重塑临床工作流程、扩展远距医疗模式以及提高诊断和治疗性介入的准确性带来了变革性的机会。要实现这一潜力，需要医疗设备製造商、网路供应商、医疗系统、监管机构和保险公司通力合作，协调产品设计、连接保障、临床检验和商业性奖励。无论产品类型和应用领域如何，通用要素包括：确定性的效能、安全且可审计的资料处理，以及可证明的临床价值—将连接性视为设备固有的属性而非附加功能。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：5G相容医疗设备市场：依产品类型划分

  • 诊断设备
    • 诊断影像
      • CT扫描仪
      • 核磁共振扫描仪
      • 超音波诊断设备
    • 临床检测
      • 血液分析仪
      • 尿液检查装置
    • 即时诊断
  • 监控设备
    • 心电图监测
      • 居家心电图监测
      • 医院用心电图监测
    • 血糖监测
      • 持续血糖监测
      • 间歇性血糖监测
    • 呼吸监测
      • 睡眠呼吸中止监测
      • 肺功能监测
    • 生命征象监测
      • 血压监测
      • 心率监测
      • 体温监测
  • 治疗设备
    • 点滴帮浦
      • 胰岛素注射
      • 点滴镇痛
    • 胰岛素帮浦
      • 补片泵浦
      • 管式帮浦
    • 神经刺激设备
      • 深部脑部刺激器
      • 脊髓刺激设备
    • 呼吸治疗设备
      • CPAP设备
      • 人工呼吸器

第九章：按连线类型分類的5G相容医疗设备市场

  • 非独立组网 5G
    • 毫米波
    • 低于 6GHz
  • 私有5G
    • 校园网络
    • 工业网络
  • 独立组网 5G
    • 毫米波
    • 低于 6GHz

第十章：以网路架构分類的5G相容医疗设备市场

  • 混合网路
    • 边缘集成
    • 本地核心
  • 私人网路
    • 校园网络
    • 企业网路
  • 公共网路
    • MVNO
    • 通讯业者网络

第十一章：5G相容医疗设备市场：按组件划分

  • 硬体
    • 天线
    • 模组
      • 连接模组
      • 电源模组
    • 感应器
  • 服务
    • 咨询服务
    • 综合服务
    • 维护服务
  • 软体
    • 分析软体
    • 行动应用
    • 平台

第十二章：5G相容医疗设备市场：依应用领域划分

  • 资产追踪
    • 装置追踪
      • 设备位置
      • 穿戴式资产追踪
    • 供应链监控
      • 低温运输监测
      • 库存视觉化
  • 紧急应变
    • 救护车服务
      • 移动诊断
      • 紧急情况下的远端医疗
    • 灾害管理
      • 野战医院的建设
      • 远端协作
  • 远端患者监护
    • 慢性病管理
      • 心臟护理
      • 糖尿病管理
    • 老年护理
      • 活动监测
      • 跌倒侦测
    • 术后护理
      • 疼痛管理
      • 伤口监测
  • 智慧医院
    • 资产管理
      • 装置追踪
      • 库存管理
    • 即时定位服务
      • 资产追踪
      • 患者追踪
    • 员工管理
      • 员工追踪
      • 工作流程优化
  • 远端医疗
    • 紧急远距会诊
      • 救护车远端保健
      • 灾难远距远距照护
    • 视讯咨询
      • 人工智慧辅助诊断
      • 即时高清影像
    • 虚拟重症监护室
      • 警报管理
      • 远端患者监护

第十三章：5G相容医疗设备市场：依最终用户划分

  • 门诊手术中心
    • 医院相关
    • 独立的
  • 诊所
    • 门诊部
    • 专科诊所
  • 居家医疗
    • 病人家
    • 老年护理机构
  • 医院
    • 私立医院
    • 公立医院
  • 远端医疗提供者
    • 平台提供者
    • 服务聚合器

第十四章：5G相容医疗设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：5G相容医疗设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：5G赋能的医疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国5G相容医疗设备市场

第十八章：中国的5G相容医疗设备市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Bharti Airtel Limited
  • Boston Scientific Corporation
  • China Mobile Limited
  • Deutsche Telekom AG
  • Fibocom Wireless Inc.
  • GE Healthcare Technologies Inc.
  • General Electric Company
  • Intel Corporation
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic plc
  • Quectel Wireless Solutions Co., Ltd.
  • Samsung Electronics Co., Ltd
  • Siemens Healthineers AG
  • Sierra Wireless, Inc.
  • Swisscom AG
  • Telefonica, SA
  • Vodafone Group Public Limited Company
  • ZTE Corporation
Product Code: MRR-AD517FAA8AD0

The 5G-enabled Medical Devices Market was valued at USD 1.22 billion in 2025 and is projected to grow to USD 1.51 billion in 2026, with a CAGR of 23.62%, reaching USD 5.38 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.22 billion
Estimated Year [2026] USD 1.51 billion
Forecast Year [2032] USD 5.38 billion
CAGR (%) 23.62%

An authoritative introduction outlining how fifth-generation connectivity is redefining clinical devices and delivery models across healthcare ecosystems

The deployment of fifth-generation wireless connectivity is reshaping the design, delivery, and management of medical devices across clinical and non-clinical settings. This report examines how deterministic connectivity, ultra-low latency, and high device density enable new classes of diagnostic, monitoring, and therapeutic devices while imposing fresh requirements on cybersecurity, regulatory compliance, and clinical validation. Stakeholders from device manufacturers to health system operators and network providers confront a rapidly evolving technical and commercial landscape where interoperability, data integrity, and patient safety sit at the intersection of innovation and regulation.

As care delivery models continue to decentralize, the interplay between on-premise infrastructure and cloud-based analytics is becoming central to device value propositions. Remote patient management, telehealth modalities, and smart hospital initiatives now depend on predictable connectivity and resilient network architectures. Consequently, product road maps are shifting to embed network adaptability, edge compute capabilities, and secure telemetry from initial design phases.

The introduction frames current dynamics by describing the principal technological enablers and the operational pressures that drive adoption. It also identifies the core stakeholders whose choices will determine how rapidly the theoretical benefits of 5G become realized in everyday clinical workflows. Finally, the introduction outlines the report's scope and analytical approach, setting expectations for how subsequent sections translate complex technical trends into operational priorities for device manufacturers, health systems, and technology partners.

A concise analysis of the major technological, regulatory, and operational shifts that are accelerating adoption and raising the bar for clinical-grade connectivity

The last several years have seen a suite of transformative shifts that are accelerating the adoption of connected medical devices and reframing clinical workflows. First, the maturation of edge computing and distributed analytics has reduced the friction between data capture and clinical action, enabling real-time decision support for high-acuity use cases. At the same time, the expansion of private and hybrid network deployments has created controlled connectivity environments where latency, throughput, and security parameters can be managed to meet clinical grade requirements.

Second, advances in radio access technologies and spectrum allocation-particularly the dual play of mmWave and Sub6GHz bands-are unlocking differentiated performance capabilities that map directly to device classes such as high-resolution imaging and continuous physiological monitoring. This technical diversity is prompting OEMs to pursue modular hardware and software architectures that can operate across NonStandalone, Standalone, and private 5G configurations.

Third, the convergence of AI-driven analytics with richer telemetry has increased the clinical value of continuous monitoring and point-of-care diagnostics, while simultaneously raising expectations for explainability, validation, and governance. Regulatory frameworks and reimbursement pathways are adapting, but unevenly, which means innovators must navigate heterogeneous approval landscapes and payer incentives. Finally, cybersecurity threats have intensified as devices proliferate and edge compute surfaces expand. As a result, secure-by-design practices, zero-trust architectures, and supply chain transparency are no longer optional but essential components of go-to-market strategies. Collectively, these shifts are creating both new opportunities for clinical impact and heightened requirements for cross-industry collaboration.

A pragmatic assessment of how US tariff measures in 2025 have reshaped supply chain strategies, procurement dynamics, and device deployment timelines

The United States tariff environment implemented in 2025 has introduced a series of cumulative effects that ripple through supply chains, procurement strategies, and product cost structures for medical device manufacturers reliant on global component sourcing. Manufacturers that depend on foreign-produced radios, semiconductor modules, or specialized sensors are encountering elevated landed costs and longer lead times, which in turn forces reprioritization of procurement pipelines and inventory management. These pressures create incentives for diversification of suppliers, increased onshoring of critical components, and strategic partnership agreements that can buffer exposure to future policy changes.

Procurement teams within health systems and device OEMs are reassessing vendor agreements to lock in pricing or shift to alternative suppliers with more favorable tariff exposure. Clinical device procurement cycles may lengthen as contracting stakeholders require additional due diligence around total cost of ownership, including tariff-related variability. From a regulatory and certification perspective, shifting components to new suppliers or manufacturing sites necessitates renewed testing and documentation, potentially extending time-to-deployment for devices undergoing wireless integration or clinical trials.

Investors and corporate strategy teams are responding by accelerating supply chain mapping and scenario planning, focusing on supplier concentration risks and redesign opportunities that reduce dependency on tariff-exposed inputs. At the same time, network operators and integrators who provide private and hybrid 5G services are adjusting commercial models to accommodate procurement uncertainty among their device customers. The net effect is an environment where strategic resilience, flexible architecture design, and supplier relationships become decisive competitive differentiators in the rollout of 5G-enabled medical technologies.

A comprehensive and integrated segmentation analysis showing how product types, applications, end users, connectivity, architecture, and components influence strategy and design

Segmentation reveals how adoption patterns and product design priorities diverge across device classes, application domains, end users, connectivity types, network architectures, and component stacks. In product type segmentation, diagnostic devices include imaging diagnostics, laboratory diagnostics, and point-of-care diagnostics where imaging diagnostics further bifurcate into CT scanners, MRI scanners, and ultrasound devices while laboratory diagnostics separate into blood analyzers and urinalysis analyzers; these high-bandwidth, high-accuracy instruments prioritize throughput, deterministic connectivity, and secure data pipelines. Monitoring devices encompass cardiac monitoring, glucose monitoring, respiratory monitoring, and vital signs monitoring, with cardiac monitoring split into home and hospital categories, glucose monitoring differentiated between continuous and intermittent approaches, respiratory monitoring addressing sleep apnea and spirometry, and vital signs monitoring covering blood pressure, heart rate, and temperature; these monitoring segments prioritize low power consumption, continuity of telemetry, and robust edge analytics. Therapeutic devices include infusion pumps, insulin pumps, neurostimulators, and respiratory therapy devices, with infusion pumps subdivided into insulin infusion and pain management infusion, insulin pumps into patch and tubed variants, neurostimulators into deep brain and spinal cord stimulators, and respiratory therapy devices into CPAP machines and ventilators; therapeutic segments demand ultra-reliable connectivity, fail-safe behaviors, and rigorous device interoperability.

Application segmentation groups solutions across asset tracking, emergency response, remote patient monitoring, smart hospital, and telemedicine. Asset tracking separates into device tracking and supply chain monitoring where device tracking parses into equipment positioning and wearable asset tracking while supply chain monitoring splits into cold chain oversight and inventory visibility. Emergency response includes ambulance services and disaster management, with ambulance services further distinguishing mobile diagnostics and prehospital telehealth and disaster management covering field hospital enablement and remote coordination. Remote patient monitoring subdivides into chronic disease management, elderly care, and postoperative care; chronic disease management further divides into cardiac care and diabetes management, elderly care emphasizes activity monitoring and fall detection, and postoperative care focuses on pain and wound monitoring. Smart hospital use cases include asset management, real-time location services, and staff management, with asset management covering equipment tracking and inventory control, real-time location services differentiating between asset and patient tracking, and staff management addressing personnel tracking and workflow optimization. Telemedicine includes emergency teleconsultation, video consultation, and virtual ICU where emergency teleconsultation separates into ambulance telehealth and disaster telecare, video consultation benefits from AI-assisted diagnostics and real-time HD video, and virtual ICU focuses on alarm management and remote surveillance.

End-user segmentation captures ambulatory surgical centers, clinics, home healthcare, hospitals, and telehealth providers. Ambulatory surgical centers are classified as hospital-affiliated or independent while clinics differentiate outpatient and specialty clinics. Home healthcare distinguishes between patient homes and senior care facilities. Hospitals classify as private or public, and telehealth providers separate into platform providers and service aggregators. Connectivity type segmentation contrasts NonStandalone 5G, Private 5G, and Standalone 5G; NonStandalone and Standalone each extend across mmWave and Sub6GHz bands, while Private 5G distinguishes campus networks and industrial networks. Network architecture segmentation contrasts hybrid, private, and public networks where hybrid architectures emphasize edge integration and on-premise core options, private networks break down into campus and enterprise footprints, and public networks cover MVNO and operator-managed models. Component segmentation clarifies hardware, services, and software requirements; hardware covers antennas, modules, and sensors with modules split into connectivity and power variants, services encompass consulting, integration, and maintenance, and software ranges from analytics suites to mobility applications and platform orchestration. Together, these layered segmentation perspectives illuminate where design trade-offs, commercialization tactics, and clinical validation efforts must be concentrated for each product and use-case class.

A strategic regional overview explaining how Americas, Europe Middle East & Africa, and Asia-Pacific each present distinct adoption drivers and deployment priorities

Regional dynamics materially influence technology adoption curves, regulatory priorities, and commercial partnerships across the 5G-enabled medical device landscape. In the Americas, health systems and device manufacturers emphasize rapid trials of connectivity-enabled solutions, driven by a combination of private network pilots in academic medical centers and strong demand for telemedicine and remote patient monitoring. North American purchasers exhibit heightened sensitivity to cybersecurity and compliance pathways, and payers increasingly reward devices that deliver measurable reductions in acute care utilization. Procurement cycles in this region tend to favor integrated solutions that demonstrate clear clinical and operational ROI, and partnerships between device OEMs and large network providers are common to de-risk deployments.

In Europe, Middle East & Africa, regulatory harmonization and cross-border interoperability are central themes. European Union regulatory frameworks and national health systems drive technical and clinical standards, creating a premium for devices that can demonstrate multi-jurisdictional compliance. In the Middle East, rapid investments in smart hospital infrastructures and private network deployments foster early-adopter environments, while parts of Africa present unique opportunities for low-bandwidth, resilient connectivity models that prioritize cost-effective remote care and supply chain visibility. Across the region, public-private partnerships and consortium approaches frequently accelerate infrastructure deployments and clinical pilots.

Asia-Pacific exhibits a mix of advanced manufacturing capability and aggressive digital health adoption. Several markets in this region lead in private 5G deployments and large-scale smart hospital initiatives, and there is substantial momentum around integrating AI diagnostics with high-throughput imaging equipment. At the same time, variation in reimbursement models and fragmented clinical procurement channels requires vendors to tailor go-to-market strategies by country. Supply chain resilience is a strategic priority here as manufacturers balance proximity to component ecosystems with the need to mitigate tariff and geopolitical disruptions. Collectively, regional profiles underscore that device developers must align product strategies with localized regulatory, reimbursement, and infrastructure realities to accelerate adoption and scale.

An incisive review of competitive roles, partnership models, and strategic imperatives shaping providers, integrators, and software partners in the ecosystem

Competitive dynamics in the 5G-enabled medical device space are shaped by a diverse set of players including device OEMs, network operators, cloud and analytics providers, systems integrators, and specialized software vendors. Device OEMs are extending their product portfolios to incorporate embedded connectivity and edge compute capabilities, and they increasingly partner with telecom providers and integrators to validate end-to-end solutions in clinical environments. Network operators and private network specialists are positioning managed connectivity and assurance services as an integral part of clinical solution stacks, offering service-level agreements and interoperability guarantees tailored to healthcare use cases.

Cloud and analytics vendors contribute scalable compute and AI capabilities that accelerate the translation of raw telemetry into clinically actionable insights, while systems integrators play a crucial role in orchestrating device interoperability, clinical workflow integration, and onsite deployment. Software developers focusing on device management, mobility applications, and analytics platforms bring domain expertise in data normalization, device lifecycle management, and regulatory documentation. Startups and niche vendors often advance specialized capabilities-such as low-power telemetry modules or explainable AI for diagnostics-that incumbents can acquire or integrate through strategic partnerships.

Strategic imperatives for market players include demonstrating clinical utility through rigorous validation, ensuring secure and auditable data flows, and building commercial models that align with payer incentives. Partnerships that combine clinical credibility, network assurance, and cloud-native analytics tend to secure early deployments, while vertically integrated approaches may offer speed-to-market advantages in environments where procurement preferences favor single-vendor accountability. For many organizations, the path to scale lies in flexible alliance models that balance proprietary innovation with interoperable standards-based architectures.

A pragmatic set of prioritized, implementable recommendations for manufacturers, health systems, and technology partners to accelerate secure and scalable deployments

Leaders planning to capitalize on 5G-enabled medical devices should prioritize a set of concrete, actionable strategies that align technical capability with clinical and commercial objectives. First, incorporate secure-by-design principles and zero-trust architectures from initial product design through to post-market surveillance to mitigate cyber risk and satisfy regulatory expectations. Early investment in hardware modularity and software-defined radio approaches will allow products to operate across NonStandalone, Standalone, and private network configurations, reducing redesign costs and accelerating deployment readiness.

Second, establish diversified supplier relationships and regional manufacturing options to manage exposure to tariff and geopolitical shocks. Scenario-based supply chain modeling and multi-sourcing strategies will reduce single-point dependencies while preserving time-to-market. Third, develop rigorous clinical validation pathways that integrate connectivity performance as part of clinical endpoints; demonstrate not only device accuracy but also the reliability of end-to-end telemetry and the clinical impact of near-real-time decision support. Fourth, form pragmatic commercial partnerships with network providers, systems integrators, and analytics vendors to offer bundled solutions that match purchaser preferences for integrated accountability.

Fifth, engage proactively with regulators and payers to shape reimbursement and compliance frameworks that recognize the value of continuous monitoring, telemedicine, and edge analytics. Collaborative pilot programs with health systems can create compelling evidence for adoption and reimbursement. Finally, invest in workforce capabilities-both within product teams and customer support functions-so that organizations can manage complex hybrid deployments, provide rapid field support, and translate technical performance into clinician-facing value propositions.

A transparent explanation of the multi-method research approach combining primary interviews, technical validation, supply chain mapping, and scenario analysis

This research draws on a multi-method approach designed to triangulate technical, clinical, and commercial perspectives on 5G-enabled medical devices. Primary qualitative inputs included structured interviews with clinical leaders, device engineers, networking specialists, and procurement executives to capture firsthand implementation experiences and pain points. Expert panels validated technical assumptions related to radio propagation, edge compute placement, and interoperability constraints. Secondary research encompassed standards documentation, regulatory guidance, technical whitepapers, and publicly available case studies to ground the analysis in established practices and recent deployments.

Technical validation involved performance testing scenarios that map device bandwidth and latency requirements to NonStandalone, Standalone, and private 5G configurations, and architecture modeling examined trade-offs between on-premise cores, hybrid edge integration, and public network dependence. Supply chain mapping identified component concentration risks and potential mitigation strategies in the context of tariff-induced disruption. The synthesis applied scenario analysis to explore alternative adoption paths under differing regulatory, economic, and infrastructure conditions.

Limitations of the methodology include variability in regulatory timelines across jurisdictions and the pace of commercial deployments, which can affect the generalizability of individual case studies. To address these constraints, findings were cross-verified across multiple expert cohorts and technical representatives. The methodology emphasizes transparency in assumptions and provides clear traceability from empirical inputs to analytical conclusions, offering readers a robust foundation for strategic decision-making while acknowledging evolving dynamics in technology and policy.

A concise conclusion emphasizing the essential priorities for translating 5G technical capability into clinical value and sustainable commercial advantage

The introduction of reliable 5G connectivity into medical devices presents a transformative opportunity to reconfigure clinical workflows, expand remote care models, and enhance the fidelity of diagnostic and therapeutic interventions. Realizing this potential requires a coordinated response from device manufacturers, network providers, health systems, regulators, and payers that aligns product design, connectivity assurance, clinical validation, and commercial incentives. Across product types and application domains, the common threads are deterministic performance, secure and auditable data handling, and demonstrable clinical value that integrates connectivity as an intrinsic device attribute rather than an add-on.

Strategic resilience against tariff and supply chain disruptions is now a competitive necessity, prompting organizations to rethink sourcing, manufacturing footprint, and partnership strategies. Regionally differentiated adoption dynamics underscore the need for localization in regulatory strategy and go-to-market execution. Companies that combine modular product architectures, robust clinical evidence, and flexible commercial models will be best positioned to scale deployments and secure long-term partnerships with health systems.

In sum, the pathway to impact for 5G-enabled medical devices is clear: embed connectivity and security into design, validate clinical and operational performance rigorously, and pursue adaptive supply chain and partnership strategies that align with evolving regulatory and procurement landscapes. Stakeholders that act decisively on these priorities can accelerate the translation of technical capability into measurable improvements in care delivery and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. 5G-enabled Medical Devices Market, by Product Type

  • 8.1. Diagnostic Devices
    • 8.1.1. Imaging Diagnostics
      • 8.1.1.1. CT Scanners
      • 8.1.1.2. MRI Scanners
      • 8.1.1.3. Ultrasound Devices
    • 8.1.2. Laboratory Diagnostics
      • 8.1.2.1. Blood Analyzer
      • 8.1.2.2. Urinalysis Analyzer
    • 8.1.3. Point Of Care Diagnostics
  • 8.2. Monitoring Devices
    • 8.2.1. Cardiac Monitoring
      • 8.2.1.1. Home Cardiac Monitoring
      • 8.2.1.2. Hospital Cardiac Monitoring
    • 8.2.2. Glucose Monitoring
      • 8.2.2.1. Continuous Glucose Monitoring
      • 8.2.2.2. Intermittent Glucose Monitoring
    • 8.2.3. Respiratory Monitoring
      • 8.2.3.1. Sleep Apnea Monitoring
      • 8.2.3.2. Spirometry Monitoring
    • 8.2.4. Vital Signs Monitoring
      • 8.2.4.1. Blood Pressure Monitoring
      • 8.2.4.2. Heart Rate Monitoring
      • 8.2.4.3. Temperature Monitoring
  • 8.3. Therapeutic Devices
    • 8.3.1. Infusion Pumps
      • 8.3.1.1. Insulin Infusion
      • 8.3.1.2. Pain Management Infusion
    • 8.3.2. Insulin Pumps
      • 8.3.2.1. Patch Pumps
      • 8.3.2.2. Tubed Pumps
    • 8.3.3. Neurostimulators
      • 8.3.3.1. Deep Brain Stimulators
      • 8.3.3.2. Spinal Cord Stimulators
    • 8.3.4. Respiratory Therapy Devices
      • 8.3.4.1. CPAP Machines
      • 8.3.4.2. Ventilators

9. 5G-enabled Medical Devices Market, by Connectivity Type

  • 9.1. NonStandalone 5G
    • 9.1.1. MmWave
    • 9.1.2. Sub6GHz
  • 9.2. Private 5G
    • 9.2.1. Campus Network
    • 9.2.2. Industrial Network
  • 9.3. Standalone 5G
    • 9.3.1. MmWave
    • 9.3.2. Sub6GHz

10. 5G-enabled Medical Devices Market, by Network Architecture

  • 10.1. Hybrid Network
    • 10.1.1. Edge Integrated
    • 10.1.2. On-Premise Core
  • 10.2. Private Network
    • 10.2.1. Campus Network
    • 10.2.2. Enterprise Network
  • 10.3. Public Network
    • 10.3.1. MVNO
    • 10.3.2. Operator Network

11. 5G-enabled Medical Devices Market, by Component

  • 11.1. Hardware
    • 11.1.1. Antennas
    • 11.1.2. Modules
      • 11.1.2.1. Connectivity Modules
      • 11.1.2.2. Power Modules
    • 11.1.3. Sensors
  • 11.2. Services
    • 11.2.1. Consulting Services
    • 11.2.2. Integration Services
    • 11.2.3. Maintenance Services
  • 11.3. Software
    • 11.3.1. Analytics Software
    • 11.3.2. Mobility Applications
    • 11.3.3. Platforms

12. 5G-enabled Medical Devices Market, by Application

  • 12.1. Asset Tracking
    • 12.1.1. Device Tracking
      • 12.1.1.1. Equipment Positioning
      • 12.1.1.2. Wearable Asset Tracking
    • 12.1.2. Supply Chain Monitoring
      • 12.1.2.1. Cold Chain Monitoring
      • 12.1.2.2. Inventory Visibility
  • 12.2. Emergency Response
    • 12.2.1. Ambulance Services
      • 12.2.1.1. Mobile Diagnostics
      • 12.2.1.2. Prehospital Telehealth
    • 12.2.2. Disaster Management
      • 12.2.2.1. Field Hospital Enablement
      • 12.2.2.2. Remote Coordination
  • 12.3. Remote Patient Monitoring
    • 12.3.1. Chronic Disease Management
      • 12.3.1.1. Cardiac Care
      • 12.3.1.2. Diabetes Management
    • 12.3.2. Elderly Care
      • 12.3.2.1. Activity Monitoring
      • 12.3.2.2. Fall Detection
    • 12.3.3. Postoperative Care
      • 12.3.3.1. Pain Management
      • 12.3.3.2. Wound Monitoring
  • 12.4. Smart Hospital
    • 12.4.1. Asset Management
      • 12.4.1.1. Equipment Tracking
      • 12.4.1.2. Inventory Management
    • 12.4.2. Real-Time Location Services
      • 12.4.2.1. Asset Tracking
      • 12.4.2.2. Patient Tracking
    • 12.4.3. Staff Management
      • 12.4.3.1. Personnel Tracking
      • 12.4.3.2. Workflow Optimization
  • 12.5. Telemedicine
    • 12.5.1. Emergency Teleconsultation
      • 12.5.1.1. Ambulance Telehealth
      • 12.5.1.2. Disaster Telecare
    • 12.5.2. Video Consultation
      • 12.5.2.1. AI-Assisted Diagnostics
      • 12.5.2.2. Real-Time HD Video
    • 12.5.3. Virtual ICU
      • 12.5.3.1. Alarm Management
      • 12.5.3.2. Remote Patient Surveillance

13. 5G-enabled Medical Devices Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Hospital-Affiliated
    • 13.1.2. Independent
  • 13.2. Clinics
    • 13.2.1. Outpatient Clinics
    • 13.2.2. Specialty Clinics
  • 13.3. Home Healthcare
    • 13.3.1. Patient Homes
    • 13.3.2. Senior Care Facilities
  • 13.4. Hospitals
    • 13.4.1. Private Hospitals
    • 13.4.2. Public Hospitals
  • 13.5. Telehealth Providers
    • 13.5.1. Platform Providers
    • 13.5.2. Service Aggregators

14. 5G-enabled Medical Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. 5G-enabled Medical Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. 5G-enabled Medical Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States 5G-enabled Medical Devices Market

18. China 5G-enabled Medical Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Baxter International Inc.
  • 19.7. Becton, Dickinson and Company
  • 19.8. Bharti Airtel Limited
  • 19.9. Boston Scientific Corporation
  • 19.10. China Mobile Limited
  • 19.11. Deutsche Telekom AG
  • 19.12. Fibocom Wireless Inc.
  • 19.13. GE Healthcare Technologies Inc.
  • 19.14. General Electric Company
  • 19.15. Intel Corporation
  • 19.16. Johnson & Johnson
  • 19.17. Koninklijke Philips N.V.
  • 19.18. Medtronic plc
  • 19.19. Quectel Wireless Solutions Co., Ltd.
  • 19.20. Samsung Electronics Co., Ltd
  • 19.21. Siemens Healthineers AG
  • 19.22. Sierra Wireless, Inc.
  • 19.23. Swisscom AG
  • 19.24. Telefonica, S.A.
  • 19.25. Vodafone Group Public Limited Company
  • 19.26. ZTE Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NETWORK ARCHITECTURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES 5G-ENABLED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA 5G-ENABLED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY IMAGING DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CT SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MRI SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY LABORATORY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY URINALYSIS ANALYZER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POINT OF CARE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOME CARDIAC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HOSPITAL CARDIAC MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY GLUCOSE MONITORING, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTERMITTENT GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY MONITORING, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SLEEP APNEA MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPIROMETRY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VITAL SIGNS MONITORING, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HEART RATE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TEMPERATURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PATCH PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY TUBED PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NEUROSTIMULATORS, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY RESPIRATORY THERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CPAP MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NONSTANDALONE 5G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NONSTANDALONE 5G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NONSTANDALONE 5G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NONSTANDALONE 5G, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE 5G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE 5G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE 5G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE 5G, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INDUSTRIAL NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INDUSTRIAL NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INDUSTRIAL NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY STANDALONE 5G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY STANDALONE 5G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY STANDALONE 5G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY STANDALONE 5G, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MMWAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUB6GHZ, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY NETWORK ARCHITECTURE, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HYBRID NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HYBRID NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HYBRID NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HYBRID NETWORK, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EDGE INTEGRATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EDGE INTEGRATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EDGE INTEGRATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ON-PREMISE CORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ON-PREMISE CORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ON-PREMISE CORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PRIVATE NETWORK, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CAMPUS NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ENTERPRISE NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ENTERPRISE NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ENTERPRISE NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PUBLIC NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PUBLIC NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PUBLIC NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PUBLIC NETWORK, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MVNO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MVNO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MVNO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY OPERATOR NETWORK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY OPERATOR NETWORK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY OPERATOR NETWORK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANTENNAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANTENNAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANTENNAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MODULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MODULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MODULES, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY MODULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY MODULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONNECTIVITY MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POWER MODULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POWER MODULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY POWER MODULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTEGRATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTEGRATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INTEGRATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILITY APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILITY APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILITY APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY ASSET TRACKING, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DEVICE TRACKING, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EQUIPMENT POSITIONING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY WEARABLE ASSET TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY SUPPLY CHAIN MONITORING, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COLD CHAIN MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COLD CHAIN MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY COLD CHAIN MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INVENTORY VISIBILITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INVENTORY VISIBILITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY INVENTORY VISIBILITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EMERGENCY RESPONSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EMERGENCY RESPONSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EMERGENCY RESPONSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY EMERGENCY RESPONSE, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY AMBULANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY AMBULANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY AMBULANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY AMBULANCE SERVICES, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY MOBILE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PREHOSPITAL TELEHEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PREHOSPITAL TELEHEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY PREHOSPITAL TELEHEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DISASTER MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DISASTER MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 274. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DISASTER MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY DISASTER MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY FIELD HOSPITAL ENABLEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 277. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY FIELD HOSPITAL ENABLEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY FIELD HOSPITAL ENABLEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE COORDINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 280. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE COORDINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 281. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE COORDINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 283. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 284. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY REMOTE PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 286. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 287. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 289. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 290. GLOBAL 5G-ENABLED MEDICAL DEVICES MARKET SIZE, BY CARDIAC CARE, BY REG